OraSure Technologies Inc

Financials

Gesamtvermögen 454.47 M460.99 M444.71 M482.85 M479.66 M403.17 M Gesamtverbindlichkeiten 55.9 M80.46 M81.08 M52.17 M69.32 M62.34 M Gesamtkapital 398.57 M380.53 M363.62 M430.67 M410.34 M340.83 M Gesamtverbindlichkeiten und Eigenkapital 454.47 M460.99 M444.71 M482.85 M479.66 M403.17 M Gesamtverschuldung —————— Nettoverschuldung ——————

OraSure Technologies, Inc. is a Bethlehem, Pennsylvania–based company in the medical device industry. Their products include diagnostic testing kits. The company had recently developed OraQuick testing kit, the first over-the-counter home HIV test.

OSUR

Financials

OraSure Technologies Inc

Nachrichten

Insiderkauf bei OraSure: Finanzvorstand McGrath erwirbt Aktien im Wert von 94.600 $

Insiderkauf bei OraSure: CEO Eglinton erwirbt Aktien im Wert von 94.597 US-Dollar

Altai Capital pushes for board seats at OraSure Technologies

OraSure CFO McGrath buys $66k in OSUR stock

OraSure Technologies (OSUR) president buys $66k in shares

OraSure Technologies, Inc. (OSUR) Q4 2025 Earnings Call Transcript

OraSure: EPS erfüllt Schätzungen - Umsatz schlechter als erwartet

OraSure earnings matched, revenue fell short of estimates

Earnings Call: OraSure Technologies verfehlt Umsatzprognose für Q4 2025

InfuSystems Holdings, Inc. (INFU) Q4 Earnings Beat Estimates

OraSure’s HIV self-test receives Health Canada license

Phibro Animal Health (PAHC) Q2 Earnings and Revenues Surpass Estimates